secwatch.observer — SEC 8-K summary
======================================

Issuer:     4D Molecular Therapeutics, Inc. (FDMT)
CIK:        0001650648
Form:       8-K
Filed at:   2022-02-22T23:59:59+00:00
Accession:  0001193125-22-048643
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director David Schaffer resigns from 4D Molecular Therapeutics board
--------------------------------------------------------------------

- David Schaffer resigned from the Board and its Nominating and Corporate Governance and Science & Technology Committees, effective February 17, 2022.
- He also intends to terminate his consulting agreement with the Company.
- Resignation is not due to any disagreement with the Company or Board regarding operations, policies, or practices.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1650648/000119312522048643/0001193125-22-048643-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1650648/000119312522048643/d323690d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-048643

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer